| Table 2. Patient characteristics and ART outcomes in different ovarian hyperstimulation protocol groups | |||
| Characteristics | Antagonist Protocol | Long Agonist Protocol | |
|---|---|---|---|
| n=126 | n=18 | p value | |
| Female age (years) | 31.79 (±4.75) | 30.11 (±3.50) | 0.15 |
| Male age (years) | 34.94 (±5.32) | 33.33 (±5.33) | 0.23 |
| BMI (kg/m2) | 25.45 (±4.3) | 24.61 (±4.08) | 0.49 |
| FSH (mIU/mL) | 7.25 (±2.94) | 8.20 (±4.45) | 0.25 |
| LH (IU/mL) | 5.70 (±3.96) | 5.65 (±2.06) | 0.96 |
| Glycodelin (ng/mL) | 7.01 (±4.50) | 6.68 (±4.02) | 0.77 |
| MII (n) | 6.79 (±4.63) | 10.61 (±5.65) | 0.002 |
| Fertilization (%) | 77.88 (±21.78) | 78.11 (±17.58) | 0.97 |
| GI Embryo (n) | 2.13 (±2.14) | 2.70 (±2.58) | 0.49 |
| Arrest (n) | 0.91 (±1.54) | 1.50 (±1.97) | 0.17 |
| Implantation (yes,%) | 33.6 | 38.9 | 0.66 |
| Pregnancy* (yes,%) | 27.2 | 27.8 | 0.75 |
| Values are expressed as mean ± SD. BMI, body mass index. MII, metaphase II oocytes. Pregnancy indicates clinical pregnancy rates. |
|||